IL4 and metabolic dysfunction-associated steatotic liver disease: The COPD+NAFLD group exhibited some differential metabolic and inflammatory changes, including reductions in selected pro-inflammatory cytokines, increases in IL-4 expression, and shifts in metabolic efficiency reflected by changes in RER at the anaerobic threshold and VO2 at AT.